Biology-driven therapy advances in high-grade serous ovarian cancer

Yinu Wang, Alexander James Duval, Mazhar Adli, Daniela Matei

Open source

DOI: 10.1172/jci174013
Published: 2024-01-02
Container: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1172/jci174013,
  title = {Biology-driven therapy advances in high-grade serous ovarian cancer},
  author = {Yinu Wang and Alexander James Duval and Mazhar Adli and Daniela Matei},
  year = {2024},
  journal = {Journal of Clinical Investigation},
  doi = {10.1172/jci174013},
  url = {https://doi.org/10.1172/jci174013}
}

RIS

TY  - JOUR
TI  - Biology-driven therapy advances in high-grade serous ovarian cancer
AU  - Yinu Wang
AU  - Alexander James Duval
AU  - Mazhar Adli
AU  - Daniela Matei
PY  - 2024
JO  - Journal of Clinical Investigation
DO  - 10.1172/jci174013
UR  - https://doi.org/10.1172/jci174013
ER  -

APA

Wang, Y., Duval, A. J., Adli, M., & Matei, D. (2024). Biology-driven therapy advances in high-grade serous ovarian cancer. Journal of Clinical Investigation. https://doi.org/10.1172/jci174013

Source records

crossref · retrieved 2026-09-25T20:38:31.912Z